AMRX - Amneal resubmits FDA application for Parkinson's disease drug
2024-02-08 17:12:51 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals: By Most Measures, A Fundamentally Undervalued Company
- Amneal Pharma inks licensing pact with Knight Therapeutics
- Amneal announces move to Nasdaq
- Seeking Alpha’s Quant Rating on Amneal Pharmaceuticals
- Historical earnings data for Amneal Pharmaceuticals